Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination
- 1 October 2011
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 29 (46), 8302-8308
- https://doi.org/10.1016/j.vaccine.2011.08.093
Abstract
No abstract availableKeywords
Funding Information
- CISA
- AHIP (200-2002-00732)
This publication has 23 references indexed in Scilit:
- Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in EuropeBMJ, 2011
- Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaignBMC Public Health, 2011
- Healthcare workers as parents: attitudes toward vaccinating their children against pandemic influenza A/H1N1BMC Public Health, 2010
- Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009–January 31, 2010Vaccine, 2010
- Portrait of a year-old pandemicNature, 2010
- Revisiting the possibility of serious adverse events from the whole cell pertussis vaccine: Were metabolically vulnerable children at risk?Medical Hypotheses, 2010
- Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesThe Lancet, 2009
- Identifying and Addressing Safety Signals in Clinical TrialsNew England Journal of Medicine, 2008
- Acute neurological events associated with influenza vaccination: Are the WHO criteria for assessing causality adequate?Scandinavian Journal of Infectious Diseases, 2008
- Consequence or coincidence?: The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccinesVaccine, 2005